Clinical trials

clinical trials

With our strong foundation in immunology and beta-cell biology, we are uniquely positioned to translate discoveries into therapies that can prevent or delay the progression to symptomatic type 1 diabetes. By conducting clinical trials, we take responsibility for bringing promising ideas from the lab to the people who need them.

Clinical trials projects

6/30/2026
-
6/30/2028
Baricade – preserve (Eli Lilly)

Promotors:

Chantal Mathieu

5/31/2026
-
5/31/2027
Safeguard (SAB Bio)

Promotors:

Chantal Mathieu

Kristina Casteels

12/22/2025
-
12/31/2029
βeta PRESERVE (Sanofi)

Promotors:

Kristina Casteels

Chantal Mathieu

2/2/2024
-
10/18/2028
Fabulinus (Sanofi)

Promotors:

Kristina Casteels

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and reversing the onset of symptomatic type 1 diabetes. Every contribution moves us one step closer to breakthroughs that matter.